Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
Saved in:
| Published in: | Molecular Oncology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
- Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity
- Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
- Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
- Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer
- Sequence context and methylation interact to shape germline mutation rate variation at CpG sites
- Analysis of Pathological Discrepancies Between Colposcopic Biopsy and Conization in Cytology‐Positive Cervical Lesions